Pulmonx (LUNG) Total Liabilities (2019 - 2025)

Pulmonx (LUNG) has reported Total Liabilities for 7 consecutive years, with $75.2 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Total Liabilities fell 2.42% year-over-year to $75.2 million in Q4 2025; TTM through Dec 2025 was $75.2 million, a 2.42% decrease from a year earlier, with the FY2025 full-year figure at $75.2 million, down 2.42% from the prior year.
• Total Liabilities was $75.2 million for Q4 2025 at Pulmonx, down from $78.2 million in the prior quarter.
• Over five years, Total Liabilities peaked at $78.2 million in Q3 2025 and troughed at $38.7 million in Q3 2022.
• A 5-year average of $57.0 million and a median of $58.2 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities sank 80.53% in 2021 and soared 53.08% in 2023, its largest moves.
• Over 5 years, Total Liabilities stood at $41.9 million in 2021, then decreased by 5.4% to $39.7 million in 2022, then soared by 49.91% to $59.5 million in 2023, then increased by 29.55% to $77.0 million in 2024, then dropped by 2.42% to $75.2 million in 2025.
• The last three Total Liabilities figures came in at $75.2 million (Q4 2025), $78.2 million (Q3 2025), and $78.1 million (Q2 2025), per Business Quant data.